LOADING
Comparing Merck & Company (MRK) and Thermo Fisher Scientific (TMO), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $364.0B | $224.0B |
| P/E Ratio | 119.0 | 32.5 |
| Forward P/E | 15.3 | 21.9 |
| PEG Ratio | 2.89 | 1.80 |
| EPS | $1.24 | $18.66 |
| Revenue Growth (YoY) | 5.1% | 10.5% |
| Profit Margin | 4.8% | 15.0% |
| Return on Equity | 7.0% | 13.5% |
| Dividend Yield | 2.24% | 0.30% |
| Beta | 0.23 | 0.85 |
| 52-Week High | $156.92 | $647.00 |
| 52-Week Low | $75.81 | $434.83 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Thermo Fisher Scientific has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.